Table 2.
Patient Clinical Characteristics.
| Average Age (Years ± SD) | All | 52.18 ± 13.69 | |
|---|---|---|---|
| Leiomyosarcoma | 59.2 ± 13.46 | ||
| n | % | ||
| Race | White | 12 | 41.4 |
| Black | 16 | 55.2 | |
| Hispanic | 1 | 3.4 | |
| Smooth Muscle Type (n = 29) | Leiomyoma | 11 | 37.9 |
| Leiomyomatosis | 3 | 10.3 | |
| STUMP | 5 | 17.2 | |
| Leiomyosarcoma | 10 | 34.5 | |
| Leiomyosarcoma (n = 10) | Stage | ||
| IA | 1 | 10 | |
| IIIA | 1 | 10 | |
| IIIC | 2 | 20 | |
| IVB | 6 | 60 | |
| Surgery | |||
| TAH/BSO ± LND | 6 | 60 | |
| Other | 4 | 40 | |
| Residual Disease | 2 | 20 | |
| Adjuvant Therapy | 6 | 60 | |
| Dead of Disease | 4 | 40 | |
TAH = total abdominal hysterectomy, BSO = bilateral salpingo-oophorectomy; LND = lymph node dissection; STUMP = smooth muscle tumor of undetermined malignant potential.